Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BOTULINUM TOXIN TYPE A Cause Psoriasis? 127 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Psoriasis have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 3.4% of all adverse event reports for BOTULINUM TOXIN TYPE A.

127
Reports of Psoriasis with BOTULINUM TOXIN TYPE A
3.4%
of all BOTULINUM TOXIN TYPE A reports
22
Deaths
22
Hospitalizations

How Dangerous Is Psoriasis From BOTULINUM TOXIN TYPE A?

Of the 127 reports, 22 (17.3%) resulted in death, 22 (17.3%) required hospitalization, and 22 (17.3%) were considered life-threatening.

Is Psoriasis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 127 reports have been filed with the FAERS database.

What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?

Off label use (1,785) Drug ineffective (1,175) Drug intolerance (1,004) Product use in unapproved indication (950) Headache (797) Migraine (775) Maternal exposure during pregnancy (716) Pain (714) Hypoaesthesia (703) Nausea (665)

What Other Drugs Cause Psoriasis?

SECUKINUMAB (21,976) APREMILAST (19,255) ADALIMUMAB (16,698) ETANERCEPT (10,818) RISANKIZUMAB-RZAA (6,896) METHOTREXATE (6,283) USTEKINUMAB (4,955) INFLIXIMAB (3,524) CERTOLIZUMAB PEGOL (3,428) IXEKIZUMAB (2,818)

Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Psoriasis Risk?

BOTULINUM TOXIN TYPE A vs BREMELANOTIDE BOTULINUM TOXIN TYPE A vs BRENTUXIMAB BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN BOTULINUM TOXIN TYPE A vs BREO ELLIPTA BOTULINUM TOXIN TYPE A vs BREXANOLONE

Related Pages

BOTULINUM TOXIN TYPE A Full Profile All Psoriasis Reports All Drugs Causing Psoriasis BOTULINUM TOXIN TYPE A Demographics